Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristin A Higgins
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
543 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tohoku University School of Medicine
Sendai, Aoba-ku, Japan
- Ehime University Hospital
Tōon, Ehime, Japan
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- Gunma University Hospital
Gunma, Maebashi, Japan
- Niigata University Medical and Dental Hospital
Niigata, Niigata, Japan
- Kyorin University Hospital
Mitaka-shi, Tokyo, Japan
- Hiroshima University Hospital
Hiroshima, Japan
- Shikoku Cancer Center
Matsuyama, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Memorial Hospital North
Colorado Springs, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Uchealth Memorial Hospital Central
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Cancer Care and Hematology-Fort Collins
Fort Collins, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Uchealth Greeley Hospital
Greeley, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Medical Center of the Rockies
Loveland, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jul 2019
- Primary completion
- 21 Apr 2024
- Completion
- 21 Feb 2029
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 544
- Registry id
- NCT03811002
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.